Timo Veromaa appointed chairman of Domainex

Company: Domainex Ltd

Appointee: Timo Veromaa


United Kingdom

Domainex Ltd, a privately-owned UK drug discovery company, has appointed Timo Veromaa as executive chairman. Dr Veromaa was previously president and chief executive of Biotie Therapies Corp which was acquired by Acorda Therapeutics Inc in 2016. Dr Veromaa holds a medical degree and a PhD in immunology from the University of Turku in Finland.

Domainex announced the appointment on 30 March 2017.

Copyright 2017 Evernow Publishing Ltd